PUBLICATION
India Life Sciences 2023 Pre-Release
GBR is excited to return to India to capture the growth of the country’s life sciences sector as it expands beyond its traditional role as a global supplier of affordable generics into a force of innovation in its own right.
The pharmacy of the world, India is experiencing record export pharmaceutical volumes as its life sciences industry keeps pace with a rising global population rebounding from the most pressing case of unmet medical need in recent history — the outbreak of Covid-19. At the same time, innovations within sub-sectors including digital health and medical devices are enabling Indian companies to better penetrate large swaths of the country’s domestic population that have historically been beyond the reaches of centralized healthcare schemes. Furthermore, as consumers shift their focus from illness to wellness, nutraceuticals companies thrive in a post-pandemic environment.
RELATED INTERVIEWS MORE INTERVIEWS
RELATED ARTICLES MORE ARTICLES
Finding Funding: The Diversification of the Biotech Financing Landscape
A West-Meets-East Of The Pharma Industry
RECENT PUBLICATIONS
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.
MORE PREVIOUSLY PUBLISHED
MACIG
SUBSCRIBE TO OUR NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
